abstract |
(57) [Summary]nThe present invention relates to humanized anti-B7-2 and anti-B7-1 antibodies, each antibody comprising a variable region of non-human origin and at least a portion of an immunoglobulin of human origin. The present invention also relates to methods for treating various autoimmune diseases, transplant rejection, inflammatory diseases and infections by administering humanized anti-B7-2 and anti-B7-1 antibodies. |